{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:32:41Z","timestamp":1771032761592,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:00:00Z","timestamp":1684972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-023-00817-2","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T23:04:42Z","timestamp":1684969482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Micellar Encapsulation of Propofol Reduces its Adsorption on Extracorporeal Membrane Oxygenator (ECMO) Circuit"],"prefix":"10.1208","volume":"25","author":[{"given":"Nitish","family":"Khurana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"S\u00fcnner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Imburgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Stoddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata","family":"Yellepeddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Ghandehari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"817_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2165\/00003088-200342050-00001","volume":"42","author":"ML Buck","year":"2003","unstructured":"Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet. 2003;42:403\u201317.","journal-title":"Clin Pharmacokinet."},{"key":"817_CR2","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.clinthera.2016.07.169","volume":"38","author":"J Sherwin","year":"2016","unstructured":"Sherwin J, Heath T, Watt K. Pharmacokinetics and dosing of anti-infective drugs in patients on extracorporeal membrane oxygenation: a review of the current literature. Clin Ther. 2016;38:1976\u201394.","journal-title":"Clin Ther."},{"key":"817_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/FJC.0b013e318213aac2","volume":"58","author":"K Watt","year":"2011","unstructured":"Watt K, Li JS, Benjamin DK, Cohen-Wolkowiez M. Pediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenation. J Cardiovasc Pharmacol. 2011;58:126\u201332.","journal-title":"J Cardiovasc Pharmacol."},{"key":"817_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ejpb.2006.06.005","volume":"64","author":"JJ Palmgr\u00e9n","year":"2006","unstructured":"Palmgr\u00e9n JJ, M\u00f6nkk\u00f6nen J, Korjamo T, Hassinen A, Auriola S. Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions. Eur J Pharm Biopharm. 2006;64:369\u201378.","journal-title":"Eur J Pharm Biopharm."},{"key":"817_CR5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1051\/ject\/200739234","volume":"39","author":"TJ Preston","year":"2007","unstructured":"Preston TJ, Hodge AB, Riley JB, Leib-Sargel C, Nicol KK. In vitro drug adsorption and plasma free hemoglobin levels associated with hollow fiber oxygenators in the extracorporeal life support (ECLS) circuit. J Extra Corpor Technol. 2007;39:234\u20137.","journal-title":"J Extra Corpor Technol."},{"key":"817_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1051\/ject\/201042199","volume":"42","author":"TJ Preston","year":"2010","unstructured":"Preston TJ, Ratliff TM, Gomez D, Olshove VE, Nicol KK, Sargel CL, Chicoine LG. Modified surface coatings and their effect on drug adsorption within the extracorporeal life support circuit. J Extra Corpor Technol. 2010;42:199\u2013202.","journal-title":"J Extra Corpor Technol."},{"key":"817_CR7","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0142-9612(00)00389-6","volume":"22","author":"JK Unger","year":"2001","unstructured":"Unger JK, Kuehlein G, Schroers A, Gerlach JC, Rossaint R. Adsorption of xenobiotics to plastic tubing incorporated into dynamic in vitro systems used in pharmacological research--limits and progress. Biomater. 2001;22:2031\u20137.","journal-title":"Biomater."},{"key":"817_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2165\/11319970-000000000-00000","volume":"49","author":"MJ Ahsman","year":"2010","unstructured":"Ahsman MJ, Hanekamp M, Wildschut ED, Tibboel D, Mathot RA. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet. 2010;49:407\u201319.","journal-title":"Clin Pharmacokinet."},{"key":"817_CR9","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1128\/AAC.01696-09","volume":"54","author":"MJ Ahsman","year":"2010","unstructured":"Ahsman MJ, Wildschut ED, Tibboel D, Mathot RA. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 2010;54:1734\u201341.","journal-title":"Antimicrob Agents Chemother."},{"key":"817_CR10","first-page":"288","volume":"19","author":"AA Harthan","year":"2014","unstructured":"Harthan AA, Buckley KW, Heger ML, Fortuna RS, Mays K. Medication adsorption into contemporary extracorporeal membrane oxygenator circuits. J Pediatr Pharmacol Ther. 2014;19:288\u201395.","journal-title":"J Pediatr Pharmacol Ther."},{"key":"817_CR11","doi-asserted-by":"publisher","first-page":"R168","DOI":"10.1186\/cc5115","volume":"10","author":"MM van der Vorst","year":"2006","unstructured":"van der Vorst MM, Wildschut E, Houmes RJ, Gischler SJ, Kist-van Holthe JE, Burggraaf J, van der Heijden AJ, Tibboel D. Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation. Crit Care. 2006;10:R168.","journal-title":"Crit Care."},{"key":"817_CR12","doi-asserted-by":"publisher","first-page":"e10938","DOI":"10.1371\/journal.pone.0010938","volume":"5","author":"ED Wildschut","year":"2010","unstructured":"Wildschut ED, de Hoog M, Ahsman MJ, Tibboel D, Osterhaus AD, Fraaij PL. Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support. PLoS One. 2010;5:e10938.","journal-title":"PLoS One."},{"key":"817_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/026765910001500104","volume":"15","author":"H Mulla","year":"2000","unstructured":"Mulla H, Lawson G, von Anrep C, Burke MD, Upton DU, Firmin RK, Killer H. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion. 2000;15:21\u20136.","journal-title":"Perfusion."},{"key":"817_CR14","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00134-007-0606-2","volume":"33","author":"NM Mehta","year":"2007","unstructured":"Mehta NM, Halwick DR, Dodson BL, Thompson JE, Arnold JH. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med. 2007;33:1018\u201324.","journal-title":"Intensive Care Med."},{"issue":"Suppl 4","key":"817_CR15","doi-asserted-by":"publisher","first-page":"S400","DOI":"10.1007\/PL00003783","volume":"26","author":"KA Thompson","year":"2000","unstructured":"Thompson KA, Goodale DB. The recent development of propofol (DIPRIVAN). Intensive Care Med. 2000;26(Suppl 4):S400\u20134.","journal-title":"Intensive Care Med."},{"key":"817_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00000542-198812000-00014","volume":"69","author":"F Servin","year":"1988","unstructured":"Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF, Farinotti R. Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiol. 1988;69:887\u201391.","journal-title":"Anesthesiol."},{"key":"817_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13054-015-0772-5","volume":"19","author":"F Lemaitre","year":"2015","unstructured":"Lemaitre F, Hasni N, Leprince P, Corvol E, Belhabib G, Fill\u00e2tre P, Luyt CE, Leven C, Farinotti R, Fernandez C, Combes A. Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood. Crit Care. 2015;19:40.","journal-title":"Crit Care."},{"key":"817_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v19.i1.10","volume":"19","author":"AV Kabanov","year":"2002","unstructured":"Kabanov AV, Alakhov VY. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug Carrier Syst. 2002;19:1\u201372.","journal-title":"Crit Rev Ther Drug Carrier Syst."},{"key":"817_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i5.20","volume":"20","author":"GS Kwon","year":"2003","unstructured":"Kwon GS. Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst. 2003;20:357\u2013403.","journal-title":"Crit Rev Ther Drug Carrier Syst."},{"key":"817_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","volume":"82","author":"AV Kabanov","year":"2002","unstructured":"Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189\u2013212.","journal-title":"J Control Release"},{"key":"817_CR21","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/MAT.0000000000001616","volume":"68","author":"CE Imburgia","year":"2022","unstructured":"Imburgia CE, Rower JE, Green DJ, Mcknite AM, Kelley WE, Reilly CA, Watt KM. Remdesivir and GS-441524 extraction by ex vivo extracorporeal life support circuits. ASAIO J. 2022;68:1204\u201310.","journal-title":"ASAIO J."},{"key":"817_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2307\/2532694","volume":"48","author":"SP Wright","year":"1992","unstructured":"Wright SP. Adjusted P-values for simultaneous inference. Biom. 1992;48:1005\u201313.","journal-title":"Biom."},{"key":"817_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93:491\u2013507.","journal-title":"Biometrika"},{"key":"817_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s42114-021-00244-x","volume":"4","author":"T He","year":"2021","unstructured":"He T, He J, Wang Z, Cui Z. Modification strategies to improve the membrane hemocompatibility in extracorporeal membrane oxygenator (ECMO). Adv Compos Hybrid Mater. 2021;4:847\u201364.","journal-title":"Adv Compos Hybrid Mater."},{"key":"817_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0168-3659(01)00275-9","volume":"72","author":"SC Kim","year":"2001","unstructured":"Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S, Seo MH. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001;72:191\u2013202.","journal-title":"J Control Release"},{"key":"817_CR26","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1021\/acs.chemrev.8b00199","volume":"118","author":"H Cabral","year":"2018","unstructured":"Cabral H, Miyata K, Osada K, Kataoka K. Block copolymer micelles in nanomedicine applications. Chem Rev. 2018;118:6844\u201392.","journal-title":"Chem Rev."},{"key":"817_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1055\/s-0037-1599150","volume":"7","author":"JM Daniel","year":"2018","unstructured":"Daniel JM, Bernard PA, Skinner SC, Bhandary P, Ruzic A, Bacon MK, Ballard HO. Hollow Fiber oxygenator composition has a significant impact on failure rates in neonates on extracorporeal membrane oxygenation: a retrospective analysis. J Pediatr Intensive Care. 2018;7:7\u201313.","journal-title":"J Pediatr Intensive Care"},{"key":"817_CR28","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/PCC.0b013e318292dd10","volume":"14","author":"L Lequier","year":"2013","unstructured":"Lequier L, Horton SB, McMullan DM, Bartlett RH. Extracorporeal membrane oxygenation circuitry. Pediatr Crit Care Med. 2013;14:S7\u201312.","journal-title":"Pediatr Crit Care Med."},{"key":"817_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fbioe.2019.00461","volume":"7","author":"G Fragomeni","year":"2019","unstructured":"Fragomeni G, Terzini M, Comite A, Catapano G. The maximal pore size of hydrophobic microporous membranes does not fully characterize the resistance to plasma breakthrough of membrane devices for extracorporeal blood oxygenation. Front Bioeng Biotechnol. 2019;7:461.","journal-title":"Front Bioeng Biotechnol."},{"key":"817_CR30","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","volume":"23","author":"G Dumortier","year":"2006","unstructured":"Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23:2709\u201328.","journal-title":"Pharm Res."},{"key":"817_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10837450.2017.1419256","volume":"24","author":"Fakhar-Ud-Din","year":"2019","unstructured":"Fakhar-Ud-Din, Khan GM. Development and characterisation of levosulpiride-loaded suppositories with improved bioavailability in vivo. Pharm Dev Technol. 2019;24:63\u20139.","journal-title":"Pharm Dev Technol."},{"key":"817_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1517\/14712598.1.4.583","volume":"1","author":"V Alakhov","year":"2001","unstructured":"Alakhov V, Klinski E, Lemieux P, Pietrzynski G, Kabanov A. Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Opin Biol Ther. 2001;1:583\u2013602.","journal-title":"Expert Opin Biol Ther."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-023-00817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-023-00817-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-023-00817-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T23:14:57Z","timestamp":1702509297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-023-00817-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,25]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1208\/s12248-023-00817-2","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,25]]},"assertion":[{"value":"30 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any conflict of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"52"}}